These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3203787)

  • 1. Intravenous amrinone therapy at home for the patient with chronic congestive heart failure.
    Moore J
    Focus Crit Care; 1988 Dec; 15(6):32-7. PubMed ID: 3203787
    [No Abstract]   [Full Text] [Related]  

  • 2. Home intermittent amrinone infusions in terminal congestive heart failure.
    Baptista RJ; Mitrano FP; Perri-LaFrancesca J
    DICP; 1989 Jan; 23(1):59-62. PubMed ID: 2718486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risks and benefits of intravenous amrinone therapy.
    Haddad A
    Home Healthc Nurse; 1992; 10(5):17-8, 70. PubMed ID: 1526796
    [No Abstract]   [Full Text] [Related]  

  • 4. Intermittent intravenous amrinone infusion: a potentially cost effective mode of treatment of patients with refractory heart failure.
    Levinoff Roth SN; Moe G
    Can J Cardiol; 1993 Apr; 9(3):231-7. PubMed ID: 8508332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intravenous amrinone in the short-term management of refractory heart failure in pregnancy.
    Jelsema RD; Bhatia RK; Ganguly S
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):935-6. PubMed ID: 1923233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous amrinone therapy: nursing implications.
    Fabius DB; Rein A
    Dimens Crit Care Nurs; 1990; 9(6):336-42. PubMed ID: 2226115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of amrinone infusion in patients with chronic heart failure.
    Manoharan S; Yadav BS; Tyagi S; Rao DK; Puri YK; Singh PP; Lochan R; Khalilullah M
    Indian Heart J; 1986; 38(5):362-6. PubMed ID: 3570319
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic changes caused by a single intravenous dose of amrinone in congestive heart failure].
    Zhi G
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):218-20. PubMed ID: 2560706
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
    Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
    Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects of intravenous perfusion of amrinone in increasing doses in 12 patients with severe heart decompensation].
    Hagemeijer F; t'Hart C; van Mechelen R; Schelling A
    Rev Med Interne; 1987; 8(2):223-9. PubMed ID: 3589216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of intravenous amrinone (Win 40680) on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine].
    Tanaka K; Takano T; Shimai S; Takada K; Koh M; Seino Y; Katoh T; Nejima J; Munakata K; Hayakawa H
    Kokyu To Junkan; 1986 Jun; 34(6):651-7. PubMed ID: 3764113
    [No Abstract]   [Full Text] [Related]  

  • 12. [Our experience with using amrinone in circulatory failure].
    Krupa M; Ilmurzyńska K; Pałko T; Wojciechowska H; Weglarz J; Mroczek J
    Pol Tyg Lek; 1990 Nov 5-12; 45(45-46):922-4. PubMed ID: 2104431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of long-term amrinone therapy in patients with congestive heart failure: a placebo controlled trial.
    Rettig G; Sen S; Fröhlig G; Schieffer H; Bette L
    Eur Heart J; 1986 Jul; 7(7):628-31. PubMed ID: 3530768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of amrinone in terminal dialysis-dependent renal failure].
    Stengele E; Trenk D
    Med Klin (Munich); 1992 May; 87(5):278-80. PubMed ID: 1614376
    [No Abstract]   [Full Text] [Related]  

  • 15. [The hemodynamic profile of the response to amrinone treatment in severe heart failure].
    Domínguez de Rozas J; García Picart J; Guindo Soldevila J; Altimiras Ruiz J; Binia Mizrahi M; Pastor Ramón E; Bayés de Luna A
    Rev Esp Cardiol; 1991 Apr; 44(4):226-32. PubMed ID: 2068366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotropic therapy in the home care setting: criteria, management, and implications.
    Mayes J; Carter C; Adams JE
    J Intraven Nurs; 1995; 18(6):301-6. PubMed ID: 8699289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
    Evans JR; Pacht K; Huss P; Unverferth DV; Bashore TM; Leier CV
    Int J Clin Pharmacol Res; 1984; 4(1):9-18. PubMed ID: 6381344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dobutamine infusion for the treatment of congestive heart failure in the home care setting.
    Coffin MR
    J Intraven Nurs; 1994; 17(3):145-50. PubMed ID: 8064499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone.
    Mattingly PM; Burnette PK; Weston MW; Manny RP
    DICP; 1990 Dec; 24(12):1172-4. PubMed ID: 2089824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.